Related Experiment Videos
PET measures of pre- and post-synaptic cardiac beta adrenergic function
Jeanne M Link1, John R Stratton, Wayne Levy
1Department of Radiology, Box 356004, University of Washington, Seattle, WA 98195, USA.
Nuclear Medicine and Biology
|December 31, 2003
Summary
Congestive heart failure patients show impaired cardiac sympathetic function compared to healthy individuals. Positron Emission Tomography imaging reveals significant differences in pre-synaptic function, impacting overall cardiac health.
Area of Science:
- Cardiology
- Nuclear Medicine
- Pharmacology
Background:
- Cardiac sympathetic dysfunction is a hallmark of congestive heart failure (CHF).
- Understanding pre- and post-synaptic adrenergic function is crucial for assessing cardiac health.
- Positron Emission Tomography (PET) offers a non-invasive method to evaluate these functions.
Purpose of the Study:
- To compare global and regional cardiac beta-adrenergic function between normal subjects and CHF patients.
- To investigate the relationship between pre-synaptic and post-synaptic adrenergic function in health and CHF.
Main Methods:
- Utilized Positron Emission Tomography (PET) for cardiac imaging.
- Employed [(11)C]-meta-hydroxyephedrine to assess pre-synaptic norepinephrine transporter function.
- Used [(11)C]-CGP12177 to measure post-synaptic beta-receptor density.
Main Results:
- Significant differences in pre-synaptic function were observed between normal subjects and CHF patients.
- Post-synaptic function did not show significant differences between the groups.
- In normal hearts, pre- and post-synaptic functions were well-matched, unlike in CHF patients where they were poorly matched.
Conclusions:
- Cardiac sympathetic pre-synaptic function is significantly altered in congestive heart failure.
- PET imaging with specific radiotracers can differentiate adrenergic function in CHF.
- This technique aids in understanding regional sympathetic function in cardiac disease.